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Background:  Immunoglobulin light chain (AL) amyloidosis is associated with higher mortality than transthyretin (TTR) amyloidosis, 
however, few data exist regarding the relationship between difference of type of amyloidosis and cardiac mortality, especially in 
hemodynamic and echocardiographic parameters.
methods:  We reviewed 54 consecutive patients with biopsy-proven cardiac amyloidosis from 1993 to 2014. Of these, 28 were AL 
amyloidosis and 26 were TTR amyloidosis. Hemodynamic, echocardiographic and clinical parameters were assessed. Patients were 
retrospectively followed for cardiac mortality.
results:  There were no differences between AL and TTR in age (66±9 vs 71±10, p=0.07). BNP level was higher in AL than in TTR 
(1143±256 vs. 386±73 pg/ml, p<0.01). In hemodynamic parameters, AL demonstrated lower cardiac output and higher left ventricular (LV) 
end-diastolic pressure than TTR, but not statistically significant (3.55±1.6 vs. 3.72±0.89 L/min, p=0.745 and 17.5±4.9 vs. 14.0±8.3 mmHg, 
p=0.179, respectively). In echocardiographic parameters, only deceleration time of early filling was significantly shorter in AL than those 
of TTR (153.9±46.6 vs. 194.0±61.3ms, p<0.05). During mean follow-up period of 785 days, 21 patients died in AL and 7 in TTR (75 vs. 
27%, P<0.01). Kaplan-Meier curve analysis demonstrated that probability of free of cardiac death was significantly lower in AL than that of 
TTR (log-rank. p<0.05). Average survival time from diagnosis to death was 251.4±103.2 days in AL, 1473.9±733.7 days in TTR (P<0.05). 
Survival rate at 1 year from diagnosis was significantly lower in AL than in TTR (13 vs. 76%, p<0.001). In AL, 1-year non-survivors showed 
shorter deceleration time than those of survivors, however, not statistically significant ( 131±30vs. 177±51ms, p=0.069).
conclusion:  AL amyloidosis showed more restrictive physiology compared with TTR amyloidosis which could cause impaired diastolic 
function and higher cardiac mortality. Furthermore, only in AL amyloidosis, more impaired diastolic function might account for poor 
prognosis. 
